ReviewBreast cancer (Dove Medical Press)2022

Cancer Treatment-Induced Bone Loss: Role of Denosumab in Non-Metastatic Breast Cancer.

Boman DhabharPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.